We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TCOM:NASDAQTrip.com Group Limited Analysis

Data as of 2026-08-31 - not real-time

$44.65

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Trip.com Group Limited is neutral at $44.65, with no clear ordering between short and long averages. It has gained 1.0% over the past 30 days. Relative strength is 45.5 — neutral — and the MACD signal is bearish. Watch $44.25 as support and $47.22 as the nearer resistance level.
On valuation the read is undervalued — an earnings multiple of 6.6, absent a reliable peer benchmark. Sell-side targets cluster 35.6% above the current quote. Revenue is growing at 17.2% on a 48.6% profit margin. The 0.57% dividend yield looks covered by current payout levels.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 24.6%, a beta of 0.68 and a maximum drawdown of 49.5%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 6/10 conviction on the long call.

Top Market Events

SINGAPORE, July 25, 2026 /PRNewswire/ -- Trip.With an upside potential of 47.29%, Trip.com Group Limited NASDAQ:TCOM is among the 12 Strong Buy Stocks with High...Loomis Sayles, an investment management company, released its “Global Growth Fund” investor letter for Q2 2026.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 54.85
  • MACD momentum is negative
  • Maximum drawdown of 49.5%

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • Trading below the 200-day average of 54.85
  • Analyst targets imply +35.6% versus the current price
  • MACD momentum is negative

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Analyst targets imply +35.6% versus the current price
  • Profit margin of 48.6% is healthy
  • Revenue growth of +17.2%

Key Metrics & Analysis

Financial Health

Revenue Growth17.20%
Profit Margin48.65%
P/E Ratio6.6
ROE20.14%
ROA3.95%
Debt/Equity18.82
P/B Ratio1.2

Technical Analysis

TrendNeutral
RSI45.5
Support$44.25
Resistance$47.22
MA 20$45.71
MA 50$44.22
MA 200$54.85
MACDBearish
VolumeStable
Fear & Greed Index94.79

Valuation

Target Price$60.52
Upside/Downside35.55%
GradeUndervalued
TypeBlend
Dividend Yield0.57%

Risk Assessment

Beta0.68
Volatility24.65%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.